Sunitinib and everolimus in pancreatic neuroendocrine tumors. [electronic resource]
Producer: 20121011Description: 394 p. digitalISSN:- 2038-2529
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease-Free Survival
- Double-Blind Method
- Everolimus
- Humans
- Hypertension -- chemically induced
- Indoles -- administration & dosage
- Neuroendocrine Tumors -- drug therapy
- Neutropenia -- chemically induced
- Pancreatic Neoplasms -- drug therapy
- Pyrroles -- administration & dosage
- Randomized Controlled Trials as Topic
- Sirolimus -- administration & dosage
- Stomatitis -- chemically induced
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.